• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heparins, coumarin, and bone density.

作者信息

Monreal M, Olive A, Lafoz E, del Rio L

出版信息

Lancet. 1991 Sep 14;338(8768):706. doi: 10.1016/0140-6736(91)91292-3.

DOI:10.1016/0140-6736(91)91292-3
PMID:1679513
Abstract
摘要

相似文献

1
Heparins, coumarin, and bone density.肝素、香豆素与骨密度。
Lancet. 1991 Sep 14;338(8768):706. doi: 10.1016/0140-6736(91)91292-3.
2
[Secondary osteoporosis induced by anticoagulants?].[抗凝剂所致继发性骨质疏松？]
Orthopade. 2001 Jul;30(7):451-5. doi: 10.1007/s001320170077.
3
Low-molecular-weight heparins, acenocoumarol and bone density.低分子量肝素、醋硝香豆素与骨密度
Haemostasis. 2001 Jan-Feb;31(1):69-70. doi: 10.1159/000054197.
4
Heparin-related osteoporosis in rats. A comparative study between unfractioned heparin and a low-molecular-weight heparin.大鼠肝素相关性骨质疏松。普通肝素与低分子量肝素的比较研究。
Haemostasis. 1990;20(4):204-7. doi: 10.1159/000216128.
5
[Secondary anticoagulant prophylaxis with low molecular heparins or oral anticoagulants and bone mineral density].[低分子肝素或口服抗凝剂的二级抗凝预防与骨密度]
Pol Arch Med Wewn. 2000 Nov;104(5):769-77.
6
[Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin].
J Mal Vasc. 1996;21(3):121-5.
7
Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.长期使用低分子量肝素或醋硝香豆素进行静脉血栓栓塞症二级预防期间的骨密度变化。
Pathophysiol Haemost Thromb. 2003 Mar-Apr;33(2):64-7. doi: 10.1159/000073848.
8
The complex clinical picture of side effects to anticoagulation.抗凝治疗副作用的复杂临床表现。
Med Clin North Am. 2010 Jul;94(4):821-34, xii-iii. doi: 10.1016/j.mcna.2010.03.003.
9
Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?综述：低分子量肝素诱导的骨质疏松症和骨质疏松性骨折：是虚构还是确有其事？
Lupus. 2010 Jan;19(1):3-12. doi: 10.1177/0961203309353171. Epub 2009 Nov 24.
10
[Complications of heparin administration].[肝素给药的并发症]
Vnitr Lek. 2006 Mar;52 Suppl 1:92-7.

引用本文的文献

1
A Literature Review of the Potential Impact of Medication on Vitamin D Status.药物对维生素D状态潜在影响的文献综述
Risk Manag Healthc Policy. 2021 Aug 14;14:3357-3381. doi: 10.2147/RMHP.S316897. eCollection 2021.
2
Anticoagulants and Osteoporosis.抗凝血剂与骨质疏松症。
Int J Mol Sci. 2019 Oct 24;20(21):5275. doi: 10.3390/ijms20215275.
3
Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis.长期低分子量肝素对非妊娠成人骨折和骨密度的影响：一项荟萃分析的系统评价
J Gen Intern Med. 2016 Aug;31(8):947-57. doi: 10.1007/s11606-016-3603-8. Epub 2016 Feb 19.
4
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.达肝素：其在预防和治疗血栓栓塞性疾病方面的药理特性及临床疗效的最新进展
Drugs. 2000 Jul;60(1):203-37. doi: 10.2165/00003495-200060010-00010.
5
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.达肝素钠。其药理学及在预防和治疗血栓栓塞性疾病中的临床应用综述。
Drugs. 1996 Aug;52(2):276-305. doi: 10.2165/00003495-199652020-00011.
6
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.血清羧基化不全骨钙素是老年女性髋部骨折风险的标志物。
J Clin Invest. 1993 Apr;91(4):1769-74. doi: 10.1172/JCI116387.
7
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.药物性骨代谢紊乱。发病率、管理与预防
Drug Saf. 1994 Jun;10(6):480-9. doi: 10.2165/00002018-199410060-00006.